Virtual reality rehabilitation for upper limb function in Parkinson's disease
Effectiveness of Virtual Reality Supported Upper Extremity Position Matching Exercises in Parkinson's Disease Patients
This study tests if virtual reality exercises can help improve arm movement and function in people with Parkinson's disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Sex | All |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 1 site (Bolu, Merkez) |
| Trial ID | NCT06147726 on ClinicalTrials.gov |
What this trial studies
This project investigates the effectiveness of virtual reality-assisted rehabilitation exercises specifically designed for upper extremity function in individuals with Parkinson's disease. The intervention includes position matching exercises tailored to the joint ranges of motion, alongside conventional physiotherapy. The study aims to address the limited rehabilitation methods available for upper limb impairments, which are common in early-stage Parkinson's disease. By focusing on improving motor function and proprioception, the study seeks to enhance the quality of life for patients affected by this condition.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with Parkinson's disease who are in Hoehn-Yahr stage 3 or below and can walk independently.
Not a fit: Patients with additional neurological diseases, severe cognitive impairment, or significant visual and auditory impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve upper limb function and daily living activities for patients with Parkinson's disease.
How similar studies have performed: While previous studies have shown positive effects of virtual reality on gait and balance in Parkinson's disease, this specific focus on upper extremity rehabilitation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Accepting to participate in the research * Being diagnosed with Parkinson's Disease by a neurologist * Continuing anti-parkinsonian medication * Hoehn-Yahr (H-Y) stage 3 and below * Ability to walk independently * To have full range of motion in shoulder abduction and elbow extension movements Exclusion Criteria: * Presence of additional neurological diseases other than Parkinson's Disease * Scores below 21 on the Montreal Cognitive Assessment Scale * Change in medication dosage in the last 1 month * Severe visual impairment or complete hearing impairment in both ears * Having a rheumatologic, musculoskeletal, etc. disease that may affect upper extremity functions * The occurrence of severe tremors or dyskinesias due to the end of the drug dose * Failing the Titmus butterfly test
Where this trial is running
Bolu, Merkez
- Faculty of Health Sciences Bolu Abant Izzet Baysal University — Bolu, Merkez, Turkey (Recruiting)
Study contacts
- Principal investigator: Ramazan Kurul, Ph.D — Abant Izzet Baysal University
- Study coordinator: Muhammed NUR OGUN, MD
- Email: drmogun@gmail.com
- Phone: +90 374 254 10 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.